Donna James - 05 May 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: Director
Signature: /s/ Mai-Khoi Nguyen-Thanh, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 05 May 2022
Net transactions value: $0
Form type: 4
Filing time: 06 May 2022, 17:06:45 UTC
Previous filing: 24 Nov 2021
Next filing: 01 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Award	$0	+4,877	+21%	$0.000000	28,124	05 May 2022	Common Stock	4,877		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Reflects a value of $205,000 divided by the closing price of common stock on the date of grant.
F3	Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

Remarks:

jamespoa.txt